Mallinckrodt began the double-blind, placebo-controlled, North American Phase III CONFIRM trial to evaluate 1 mg IV Lucassin every 6
Lucassin terlipressin: Phase III started
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Mallinckrodt began the double-blind, placebo-controlled, North American Phase III CONFIRM trial to evaluate 1 mg IV Lucassin every 6